The researcher Laura Valle has been awarded the CIBERONC 2020 award at the IV Annual CIBERONC Meeting held at the National School of Health of the Carlos III Health Institute in Madrid. Laura Valle, a principal investigator in the IDIBELL hereditary cancer group and CIBERONC researcher, has received the Best CIBERONC 2020 Researcher Award. The […]
Laura Valle has received the CIBERONC 2020 award Read More »
The new therapy, designed by the team of psychooncologist Cristian Ochoa, reduces long-term emotional distress and stress symptoms.
Positive Psychotherapy in patients who have completed cancer treatment Read More »
A group from IDIBELL and UB has demonstrated that neurons can detect a decrease in the autaptic synapse, those established with themselves, and recover the consequent fall of neurotransmission by forming and enhancing new connections.
Discovery of a new mechanism of homeostatic plasticity in autaptic neural connections Read More »
The Fibro-Covid clinical trial will evaluate the ability of pirfenidone to prevent the establishment of irreversible and progressive fibrotic lesions in the lungs after overcoming Covid-19 pneumonia.
